Bausch & Lomb (BLCO) Interest & Investment Income (2022 - 2026)
Bausch & Lomb (BLCO) posted Interest & Investment Income of $4.0 million for Q1 2026, up 33.33% on a QoQ basis from $3.0 million in Q4 2025, and up 33.33% year-over-year from $3.0 million in Q1 2025.
Bausch & Lomb (BLCO) Interest & Investment Income (2022 - 2026) Analysis & Trends
Bausch & Lomb's Interest & Investment Income history runs 5 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- Quarterly Interest & Investment Income rose 33.33% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.0 million (down 13.33% YoY) and the FY2025 annual result came in at $12.0 million, down 20.0% from the prior year.
- Interest & Investment Income was $4.0 million for Q1 2026 at Bausch & Lomb, up from $3.0 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $5.0 million in Q2 2023 and bottomed at $1.0 million in Q2 2022.
- A 5-year average of $3.2 million and a median of $3.0 million in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income soared 400.0% — and 2024, when it tumbled 40.0%.
- Bausch & Lomb's Interest & Investment Income stood at $3.0 million in 2022, then changed by 0.0% to $3.0 million in 2023, then surged by 66.67% to $5.0 million in 2024, then tumbled by 40.0% to $3.0 million in 2025, then soared by 33.33% to $4.0 million in 2026.
- Business Quant data shows BLCO's Interest & Investment Income at $4.0 million in Q1 2026, $3.0 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 3.80 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 3.91 Mn |
| 10 | Bausch & Lomb | 5.79 Bn | 5.51 Bn | 973.00 Mn | 4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 5.00 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 1.00 Mn |